Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02574455
Brief Title: ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer (ASCENT)

First Submitted : October 8, 2015
First Submitted that Met QC Criteria : October 9, 2015
First Posted : October 12, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : September 19, 2019
Last Update Posted : September 23, 2019